Sight Sciences share price logo

Sight Sciences

NASDAQ: SGHT

Small Cap

$8.32

-0.07

(-0.83%)

Live

as on

Sight Sciences Stock Performance

as on October 15, 2026 at 4:08 am IST

  • Day's Low

    Day's High

    $8.22
    $8.40
    downward going graph

    1.20%

    Downside

    0.96%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.22
    $9.71
    downward going graph

    61.36%

    Downside

    16.74%

    Upside

    downward going graph

Sight Sciences share price movements today

Previous Close
$8.39
Open
$8.22
Volume
252.9K
Market Cap
$493.9M
Day's Low - High
$8.22 - $8.40
52 Week Low - High
$3.22 - $9.71

Sight Sciences Historical Returns

1 Month Return
+ 3.2 %
3 Month Return
+ 66.14 %
1 Year Return
+ 151.95 %
3 Year Return
+ 121.96 %
5 Year Return
-62.48 %

Sight Sciences Stock Fundamentals & Key Indicators

Check Sight Sciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$493.9M

EPS (TTM)

-0.5584

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-16.05

Industry PE ratio

-8.15

PEG Ratio

-0.28

EBITDA

-25.7M

Revenue (TTM)

83.4M

Profit Margin

87.96%

Return On Equity TTM

-50.64%

Sight Sciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sight Sciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$493.9M-62.48%-16.0587.96%0.00%
Buy$117.6B-25.47%21.6366.69%3.11%
Buy$49.8B-23.57%49.6577.98%0.00%
StrongBuy$176.2B-12.72%32.7456.80%2.44%
StrongBuy$108.4B7.09%28.5065.17%1.25%

Stock Returns calculator for Sight Sciences Stock including INR - Dollar returns

The Sight Sciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Sight Sciences investment value today

Current value as on today

₹2,67,742

Returns

₹1,67,742

(+167.74%)

Returns from Sight Sciences Stock

₹1,49,850 (+149.85%)

Dollar Impact

₹17,893 (+17.89%)

Analyst Recommendation on Sight Sciences Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Sight Sciences. Average target price of $9.4

Sight Sciences Share Price Target

Get share price movements and forecasts by analysts on Sight Sciences.

What analysts predicted

11.49%UPSIDE

Target Price

$9.4

Current Price

$8.32

Analyzed by

3 Analysts

High

$9

Target

$9.40

Low

$8

Sight Sciences target price $9.4, a slight upside of 11.49% compared to current price of $8.32. According to 3 analysts rating.

Indian Investors' Interest in Sight Sciences Stock

Search interest for Sight Sciences Stock has increased by 157% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:157% versus previous 30 day period

Sight Sciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
19
21
20
19
17
19
19
20
19
23
Gross Profit
16
18
16
16
15
16
17
17
16
21
Operating Income
-14
-12
-11
-11
-13
-11
-7
-3
-12
-3
EBITDA
-14
-10
-9
-10
-12
-10
-6
-2
-11
-4
Interest Expense
1
1
1
1
1
1
1
1
-1
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-16
-12
-10
-11
-14
-11
-8
-4
-12
-4
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-16
-12
-11
-11
-14
-11
-8
-4
-12
-4
Net Profit Margin
85.50%
85.84%
83.88%
86.82%
86.21%
84.78%
86.39%
87.26%
86.19%
91.39%

Sight Sciences Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
7
23
27
48
71
81
79
77
Gross Profit
5
16
18
40
58
69
68
66
Operating Income
-14
-24
-32
-51
-83
-57
-50
-37
EBITDA
-14
-23
-31
-57
-81
-49
-45
-32
Interest Expense
-
1
2
4
4
5
4
5
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-14
-25
-34
-62
-86
-55
-51
-38
Income Tax Expense
0
0
0
0
0
0
0
0
Net Income
-14
-25
-34
-62
-86
-55
-51
-38
Net Profit Margin
68.95%
71.97%
66.68%
82.41%
82.67%
85.34%
85.50%
86.17%

Sight Sciences Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-16
-12
-11
-11
-14
-11
-8
-4
-12
-4
Operating Cash Flow
-9
-9
0
-3
-11
-7
-8
-1
-7
-5
Investing Cash Flow
0
0
0
0
-
0
0
0
0
0
Financing Cash Flow
0
0
0
5
0
0
0
1
0
0
Change in Cash
-10
-9
0
1
-11
-7
-8
0
-7
-5

Sight Sciences Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-14
-25
-34
-62
-86
-55
-51
-38
Operating Cash Flow
-14
-24
-32
-52
-75
-47
-22
-29
Investing Cash Flow
0
0
0
0
0
0
0
0
Financing Cash Flow
12
42
73
252
1
1
4
1
Change in Cash
-2
16
40
199
-75
-46
-17
-28

Global Institutional Holdings in Sight Sciences

Check out the Institutions with significant holdings in Sight Sciences.

Funds
Holdings
Vanguard
3.31%
iShares
3.18%
VANGUARD INDEX FUNDS
2.57%
Fidelity Salem Street Trust
0.82%
Fidelity Concord Street Trust
0.62%

Sight Sciences News & Key Events

  • img

    Today's Timeline - 09 September

    Tue, 09:09 PM

    -

    UnitedHealthcare expands coverage for glaucoma surgeries, effective October 1, 2025, enhancing Sight Sciences' market position.

Insights on Sight Sciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, SGHT stock has moved up by 66.1%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 19.69M → 23.38M (in $), with an average increase of 15.8% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, SGHT has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -12.97M → -4.44M (in $), with an average increase of 192.0% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, SGHT has outperformed top 5 stocks with highest market-cap in its industry

About Sight Sciences

Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.
OrganisationSight Sciences
Headquarters4040 Campbell Avenue, Menlo Park, CA, 94025, US
IndustryMedical - Devices
CEOPaul Badawi

Key Management of Sight Sciences

Name

Title

Ms. Kelly Petrucci

Senior Vice President of Market Access & Strategy

Mr. James Rodberg

CFO & Treasurer

Mr. Steve R. Tamayo Jr.

VP and Chief Ethics & Compliance Officer

Mr. Kashif Rashid J.D.

Chief Legal Officer & Corporate Secretary

Ms. Sonia Clark

Vice President of People

Mr. Brenton Taylor

Executive Vice President of Operations and R&D

Mr. Paul Badawi

Co-Founder, President, CEO & Director

Ms. Alison Perry Bauerlein

Chief Operating Officer

Dr. David Badawi M.D.

Co-Founder, CTO & Director

Ms. Kelly Vaupel

Vice President of Marketing & Commercial Strategy, Interventional Glaucoma

FAQs

What is Sight Sciences share price today?

Sight Sciences share price today is $8.32 as on . Sight Sciences share today touched a day high of $8.40 and a low of $8.22.

What is the 52 week high and 52 week low for Sight Sciences share?

Sight Sciences share touched a 52 week high of $9.71 on and a 52 week low of $3.22 on . Sight Sciences stock price today i.e. is trending at $8.32,which is 14.34% down from its 52 week high and 158.79% up from its 52 week low.

What is Sight Sciences's market capitalisation today?

Sight Sciences market capitalisation is $0.00T as on .

How to invest in Sight Sciences Stock (SGHT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Sight Sciences on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Sight Sciences Stock (SGHT) from India?

Indian investors can start investing in Sight Sciences (SGHT) shares with as little as ₹95.13999938964844 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹951.40 in Sight Sciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Sight Sciences share’s latest price of $8.32 as on October 14, 2026 at 10:38 pm IST, you will get 1.2019 shares of Sight Sciences. Learn more about fractional shares .

What are the returns that Sight Sciences has given to Indian investors in the last 5 years?

Sight Sciences stock has given -62.48% share price returns and 27.71% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?